- Home
- DMAC vs WIA Comparison
DMAC vs WIA Comparison
Compare DMAC & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMAC
- WIA
- Stock Information
- Founded
- DMAC 2000
- WIA 2003
- Country
- DMAC United States
- WIA United States
- Employees
- DMAC N/A
- WIA N/A
- Industry
- DMAC Biotechnology: Pharmaceutical Preparations
- WIA Trusts Except Educational Religious and Charitable
- Sector
- DMAC Health Care
- WIA Finance
- Exchange
- DMAC Nasdaq
- WIA Nasdaq
- Market Cap
- DMAC 185.1M
- WIA 191.5M
- IPO Year
- DMAC N/A
- WIA N/A
- Fundamental
- Price
- DMAC $4.23
- WIA $8.32
- Analyst Decision
- DMAC Strong Buy
- WIA
- Analyst Count
- DMAC 3
- WIA 0
- Target Price
- DMAC $7.00
- WIA N/A
- AVG Volume (30 Days)
- DMAC 34.2K
- WIA 39.2K
- Earning Date
- DMAC 11-13-2024
- WIA 01-01-0001
- Dividend Yield
- DMAC N/A
- WIA 12.29%
- EPS Growth
- DMAC N/A
- WIA N/A
- EPS
- DMAC N/A
- WIA N/A
- Revenue
- DMAC N/A
- WIA N/A
- Revenue This Year
- DMAC N/A
- WIA N/A
- Revenue Next Year
- DMAC N/A
- WIA N/A
- P/E Ratio
- DMAC N/A
- WIA N/A
- Revenue Growth
- DMAC N/A
- WIA N/A
- 52 Week Low
- DMAC $2.12
- WIA $7.56
- 52 Week High
- DMAC $4.95
- WIA $8.91
- Technical
- Relative Strength Index (RSI)
- DMAC 45.24
- WIA 43.85
- Support Level
- DMAC $4.14
- WIA $8.17
- Resistance Level
- DMAC $4.48
- WIA $8.34
- Average True Range (ATR)
- DMAC 0.18
- WIA 0.08
- MACD
- DMAC -0.03
- WIA -0.01
- Stochastic Oscillator
- DMAC 34.88
- WIA 42.86
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.